Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022)

Prothena Corp Public (PRTA) recorded quarterly Other Non-Current Liabilities of $553000.0 in Q4 2022, little changed quarter-over-quarter from $553000.0 in Q3 2022, and little changed on a YoY basis from $553000.0 in Q4 2021.

Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022) Analysis & Trends

Prothena Corp Public's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $553000.0 for Q4 2022.

  • In Q4 2022, Other Non-Current Liabilities changed 0.0% year-over-year to $553000.0; the TTM figure through Dec 2022 stood at $553000.0 (changed 0.0% YoY), while the FY2022 annual figure was $553000.0, changed 0.0% from the prior year.
  • Other Non-Current Liabilities was $553000.0 for Q4 2022 at Prothena Corp Public, roughly flat from $553000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $553000.0 in Q3 2018 to a low of $553000.0 in Q3 2018.
  • Historically, Other Non-Current Liabilities has averaged $553000.0 across 5 years, with a median of $553000.0 in 2018.
  • Biggest YoY gain for Other Non-Current Liabilities was 0.0% in 2019; the steepest drop was 0.0% in 2019.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $553000.0 in 2018, then changed by 0.0% to $553000.0 in 2019, then changed by 0.0% to $553000.0 in 2020, then changed by 0.0% to $553000.0 in 2021, then changed by 0.0% to $553000.0 in 2022.
  • The last three Other Non-Current Liabilities figures came in at $553000.0 (Q4 2022), $553000.0 (Q3 2022), and $553000.0 (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Prothena Corp Public 479.08 Mn 149.61 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 553,000.00
Sep 30, 2022 553,000.00
Jun 30, 2022 553,000.00
Mar 31, 2022 553,000.00
Dec 31, 2021 553,000.00
Sep 30, 2021 553,000.00
Jun 30, 2021 553,000.00
Mar 31, 2021 553,000.00
Dec 31, 2020 553,000.00
Sep 30, 2020 553,000.00
Jun 30, 2020 553,000.00
Mar 31, 2020 553,000.00
Dec 31, 2019 553,000.00
Sep 30, 2019 553,000.00
Jun 30, 2019 553,000.00
Mar 31, 2019 553,000.00
Dec 31, 2018 553,000.00
Sep 30, 2018 553,000.00
Dec 31, 2016 98,000.00
Sep 30, 2016 98,000.00